Clinical Trial Update: First-In-Human (FIH), Single Ascending Dose (SAD) Study and Multiple Ascending Dose (MAD) Study of SP-101 Injection [Phase 1]

View source ↗

Summary

This is a first-in-human Phase 1 study evaluating single ascending dose and multiple ascending dose cohorts of SP-101 injection in adults with major depressive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• SP-101 injection

Snippet

Sponsor: Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. | Conditions: Major Depressive Disorder, Healthy Volunteer | Phase 1 | Status: NOT_YET_RECRUITING